MTPN and congestive heart failure: Therefore, decreasing platelet myotrophin activity in this study may be a protective response in the pathophysiology of CHF by limiting the NF-kB activity on cardiomyocytes [25], and the initiation process of myocardial hypertrophy in response to volume overload [26].